首页 | 本学科首页   官方微博 | 高级检索  
检索        


Development of a prognostic scoring system for resectable hepatocellular carcinoma
Authors:Carlo Sposito  Stefano Di Sandro  Federica Brunero  Vincenzo Buscemi  Carlo Battiston  Andrea Lauterio  Marco Bongini  Luciano De Carlis  Vincenzo Mazzaferro
Institution:Carlo Sposito, Carlo Battiston, Marco Bongini, Vincenzo Mazzaferro, Gastrointestinal Surgery and Liver Transplantation, Fondazione IRCCS Istituto Nazionale Tumori, University of Milan, 20133 Milan, Italy;Stefano Di Sandro, Vincenzo Buscemi, Andrea Lauterio, Luciano De Carlis, General Surgery and Organ Transplants, Ospedale Niguarda Ca’Granda, 20133 Milan, Italy;Federica Brunero, Clinical Trial Office and Biomedical Statistic, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy
Abstract:AIMTo develop a prognostic scoring system for overall survival (OS) of patients undergoing liver resection (LR) for hepatocellular carcinoma (HCC).METHODSConsecutive patients who underwent curative LR for HCC between 2000 and 2013 were identified. The series was randomly divided into a training and a validation set. A multivariable Cox model for OS was fitted to the training set. The beta coefficients derived from the Cox model were used to define a prognostic scoring system for OS. The survival stratification was then tested, and the prognostic scoring system was compared with the European Association for the Study of the Liver (EASL)/American Association for the Study of Liver Diseases (AASLD) surgical criteria by means of Harrell’s C statistics.RESULTSA total of 917 patients were considered. Five variables independently correlated with post-LR survival: Model for End-stage Liver Disease score, hepatitis C virus infection, number of nodules, largest diameter and vascular invasion. Three risk classes were identified, and OS for the three risk classes was significantly different both in the training (P < 0.0001) and the validation set (P = 0.0002). Overall, 69.4% of patients were in the low-risk class, whereas only 37.8% were eligible to surgery according to EASL/AASLD. Survival of patients in the low-risk class was not significantly different compared with surgical indication for EASL/AASLD guidelines (77.2 mo vs 82.5 mo respectively, P = 0.22). Comparison of Harrell’s C statistics revealed no significant difference in predictive power between the two systems (-0.00999, P = 0.667).CONCLUSIONThis study established a new prognostic scoring system that may stratify HCC patients suitable for surgery, expanding surgical eligibility with respect to EASL/AASLD criteria with no harm on survival.
Keywords:Hepatocellular carcinoma  Liver resection  Liver cirrhosis  Prognosis  Survival study
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号